Benefits
Metabolic Health and Weight Management
OEA is a satiety and metabolic signaling molecule; Trpti's bioavailable form supports metabolic and weight management applications.
Gut Microbiome Modulation
Saanroo 2026 published trial in Gut Microbes Reports demonstrated targeted modulation of gut microbiome with Trpti.
Intestinal Barrier Function
Same trial showed improvements in intestinal barrier function — relevant to gut health and metabolic health (gut-derived inflammation contributes to metabolic dysfunction).
Inflammatory Signaling Modulation
Effects on inflammatory pathways relevant to metabolic and digestive applications.
Satiety Support
OEA's role in satiety signaling supports appetite regulation.
Mechanism of action
OEA Endogenous Satiety Signaling
OEA is produced by intestinal cells in response to dietary fat; binds PPAR-alpha receptors; signals satiety to brain via vagal nerve. Endogenous appetite regulation pathway.
PPAR-alpha Activation
OEA activates PPAR-alpha — nuclear receptor regulating fatty acid metabolism, lipogenesis, satiety.
Gut Microbiome Effects
OEA modulates gut microbiome composition supporting beneficial bacterial populations.
Intestinal Barrier Support
Supports gut barrier integrity — relevant to gut-derived inflammation and metabolic dysfunction.
Clinical trials
Human clinical trial of Trpti bioavailable OEA in overweight adults; published Gut Microbes Reports March 2026.
Overweight adults.
Targeted modulation of gut microbiome; assessments of intestinal barrier function and inflammatory signaling. Established Trpti's gut and metabolic effects.